Glaxosmithkline has no heart scarring history on C
Post# of 150151
(Total Views: 259)
Posted On: 02/13/2025 6:45:33 AM
Glaxosmithkline has no heart scarring history on Clinicaltrials. Adding LL for MF to their new mandate, would be economically smart.
Would love to know who & how many 3rd parties are sitting with Cytodyn. This is all just phenominal.
Heart scarring, also known as myocardial fibrosis, is a condition where damaged heart muscle tissue is replaced with non-functional scar tissue. This can occur after a heart attack, heart failure, or other injuries to the heart.
Causes:
Myocardial infarction (heart attack)
Heart failure
Inflammation of the heart (myocarditis)
Infections
Certain medications
Genetic conditions
https://clinicaltrials.gov/search?cond=myocar...smithkline
Would love to know who & how many 3rd parties are sitting with Cytodyn. This is all just phenominal.
Heart scarring, also known as myocardial fibrosis, is a condition where damaged heart muscle tissue is replaced with non-functional scar tissue. This can occur after a heart attack, heart failure, or other injuries to the heart.
Causes:
Myocardial infarction (heart attack)
Heart failure
Inflammation of the heart (myocarditis)
Infections
Certain medications
Genetic conditions
https://clinicaltrials.gov/search?cond=myocar...smithkline
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼